| Enzo Biochem to Present at 9th Annual Needham Healthcare Conference (Business Wire) NEW YORK----Enzo Biochem, Inc. , a vertically integrated biotechnology company engaged in the research, development, manufacture, licensing and marketing of innovative health care products, platforms and services based on molecular and cellular technologies, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the 9th annual Needham Healthcare Conference on Thursday, June 10th, 2010 at 3:20 PM at The New York Palace Hotel in New York, N.Y. us.rd.yahoo.com |
GE, Intel Form Health Joint Venture General Electric and Intel announced plans to create a health-care joint venture focused on chronic disease and age-related conditions. online.wsj.com |
Global Factors Boosting Biotech Today Research Recap submits: Plunkett Research provides a ready-reference guide to the Biotechnology and Genetics Industry in 2011 in this complimentary download from the Alacra Store. Trends analyzed range from the convergence of nanotechnology and biotechnology, to the evolution of breakthrough new drug delivery systems, to the abounding ethical issues connected with biotech. Topics include: biotechnology funding and investments, FDA, gene therapies, personalized medicine, systems biology, clinical trials, stem cells, therapeutic cloning, nanotechnology, agricultural biotechnology (GM seeds), drug delivery systems and ethical issues. Plunkett cites the following global factors boosting biotech today:Complete Story » seekingalpha.com |
U.S. Sues Michigan Blue Cross The Justice Department filed an antitrust lawsuit Monday against Blue Cross Blue Shield of Michigan, alleging that provisions of the insurer's agreements with hospitals are anticompetitive. online.wsj.com |
Cardiovascular risk reduction for diabetics? - Video ACCORD Lipid Study brings new hope to people with type 2 diabetes and atherogenic dyslipidemia says international academic foundation feedproxy.google.com |